Abstract
Background
People who inject drugs in North America often continue to inject while hospitalized, and are at increased risk of premature hospital discharge, unplanned readmission, and death. In-hospital access to sterile injection supplies may reduce some harms associated with ongoing injection drug use. However, access to needle and syringe programs in acute care settings is limited. We explored the implementation of a needle and syringe program integrated into a large urban tertiary hospital in Western Canada. The needle and syringe program was administered by an addiction medicine consult team that offers patients access to specialized clinical care and connection to community services.
Methods
We utilized a focused ethnographic design and semi-structured interviews to elicit experiences and potential improvements from 25 hospitalized people who inject drugs who were offered supplies from the needle and syringe program.
Results
Participants were motivated to accept supplies to prevent injection-related harms and access to supplies was facilitated by trust in consult team staff. However, fears of negative repercussions from non-consult team staff, including premature discharge or undesired changes to medication regimes, caused some participants to hesitate or refuse to accept supplies. Participants described modifications to hospital policies regarding inpatient drug use or access to an inpatient supervised consumption service as potential ways to mitigate patients’ fears.
Conclusions
Acute care needle and syringe programs may aid hospital providers in reducing harms and improving hospital outcomes for people who inject drugs. However, modifications to hospital policies and settings may be necessary.
Funder
M.S.I. Foundation
Royal Alexandra Hospital Foundation
PolicyWise for Children and Families
Alberta Health Services
College of Physicians and Surgeons of Alberta
Publisher
Public Library of Science (PLoS)
Reference60 articles.
1. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010;L Degenhardt;Lancet,2013
2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review;L Degenhardt;Lancet Glob Health,2017
3. World Health Organization, Department of HIV/AIDS. Guide to starting and managing needle and syringe programmes [Internet]; 2007 [cited 21 Mar 2023]. Available from: https://www.unodc.org/documents/hiv-aids/NSP-GUIDE-WHO-UNODC.pdf
4. World Health Organization. Evidence for Action Technical Papers: Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users [Internet]; 2004 [cited 21 Mar 2023]. Available from https://www.unodc.org/documents/hiv-aids/EFA%20effectiveness%20sterile%20needle.pdf
5. Harm Reduction International. The global state of harm reduction 2022 [Internet]. 2022 [cited 21 Mar 2023]. Available from: https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2022/